CoChat

On central effects of serotonin re-uptake inhibitors: Quantitative EEG and psychometric studies with sertraline and zimelidine

Saletu, B., Gr�nberger, J., Linzmayer, L. · 1986 · Journal of Neural Transmission

The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.

Abstract

In a double-blind placebo-controlled cross-over study the encephalotropic and psychotropic properties of sertraline--a new potent and highly selective inhibitor of synaptosomal serotonin uptake--were studied along with blood levels of the parent drug and main metabolite in ten normal healthy volunteers. They received randomized at weekly intervals oral single doses of placebo, 100, 200 and 400 mg setraline and 100 mg zimelidine as reference drug. Blood sampling, EEG recordings, psychometric tests and evaluation of pulse, blood pressure and side-effects were carried out at the hours 0, 2, 4, 6, and 8. Blood level investigations demonstrated that sertraline is slowly absorbed with dose-dependent blood concentrations peaking in the 4th to 6th hour and remaining high thereafter, while the main metabolite, CP-53261 exhibited an even slower rise in plasma concentration up to the 8th hour. Computer-assisted spectral analysis of the EEG demonstrated slight effects of 100 mg zimelidine and 100 mg sertraline on human brain function, but moderate to marked effects after 200 and 400 mg sertraline as compared with placebo. Changes after 100 mg sertraline and the reference compound resembled the pharmaco-EEG profiles of antidepressants of the desipramine type and were indicative of some vigilance-improving properties while higher doses of sertraline induced alterations reminiscent of those after antidepressants of the imipramine type, thereby reflecting vigilance changes of the dissociativ…

Overview

Integrity signals

Registry

Crossref · 10.1007/bf01243351

Cites

42 of 42 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 42 references

Research works printed but not linked: 8

  1. Grünberger J (1977) Psychodiagnostik des Alkoholkranken. Methodischer Beitrag zur Bestimmung der Organizität in der Psychiatrie. Maudrich, Wien
  2. Grünberger J, Linzmayer L, Saletu B (1984) Klinische Psychodiagnostik mit Hilfe psychophysiologischer Verfahren. Wien Med Wschr 134: 29?35
  3. Pfizer (1982) Central research: sertraline (CP-51, 974) ? investigators reference manual. Sandwich, England
  4. Saito M, Kita S, Kagono Y (1982) The orientation of psychotropic drug properties based on the induced changes in electroencephalogram. Studies on zimelidine and sulpiride. In: Herrmann WM (ed) EEG in drug research. G. Fischer, Stuttgart New York, pp 51?74
  5. Saletu B (1976) Psychopharmaka, Gehirntätigkeit und Schlaf. Karger, Basel
  6. Saletu B (1981) Application of quantitative EEG in measuring encephalotropic and pharmacodynamic properties of antihypoxidotic/nootropic drugs. In: Scientific International Research (ed) Drugs and methods in C.V.D. Pergamon Press, Oxford
  7. Spiegel R, Aebi H-J (1981) Psychopharmakologie. W Kohlhammer, Stuttgart Berlin Köln Mainz
  8. Zerssen VC, Koeller DM, Rey ER (1970) Die Befindlichkeitsskala (B-S) ? ein einfaches Instrument zur Objektivierung von Befindlichkeitsstörungen, insbesondere im Rahmen von Längsschnittuntersuchungen. Arzneim-Forsch 20: 915?918

Cited by

Metadata

Authors
Saletu, B., Gr�nberger, J., & Linzmayer, L.
Affiliations
University of Vienna (AT)
Venue
Journal of Neural Transmission
Published
1986-09
Volume
67
Issue
3-4
Pages
241-266
ISSN
  • 0300-9564 (ISSN-L)
  • 1435-1463
OpenAlex
W2035578288
Cited by
78
References
42
Citations by year
2026: 1 · 2024: 2 · 2022: 2 · 2021: 1 · 2020: 1 · 2019: 2 · 2018: 1 · 2017: 2 · 2016: 2 · 2015: 1 · 2014: 3 · 2013: 2 · 2012: 2
FWCI
1.89
Type
journal article
Language
en
Open access
closed
Licence
www.springer.com/tdm (tdm)
Locations
  • Journal of Neural Transmission (publishedVersion)
  • PubMed (publishedVersion)
Funders
Pfizer
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
sertraline, zimelidine, selective serotonin reuptake inhibitors, pharmaco-EEG, plasma drug concentration, dose-dependent effects, sustained attention, psychometric performance, psychophysiological effects, pupil dilation, antidepressants, pharmacodynamics, adverse effects, blood pressure, pulse rate
MeSH terms
Adult, Brain, Double-Blind Method, Electroencephalography, Female, Humans, Male, Mental Processes, Naphthalenes, Psychological Tests, Psychotropic Drugs, Zimeldine, 1-Naphthylamine, Sertraline

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.